Report #2834063

Received Apr 2, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 67 yrs
State: TX
Recovered: Not recovered
Vaccinated: Mar 27, 2025
Onset: Mar 29, 2025
Days to onset: 2
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	944942	IM / LA
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	N/A	Y013009	IM / LA
TDAP	TDAP (BOOSTRIX)	GLAXOSMITHKLINE BIOLOGICALS	N/A	L5229	IM / LA

Symptoms (2)

Injection site erythemaInjection site warmth

Symptom narrative

Patient started getting redness on the left arm at the site of injection on Saturday 3/29/25, 2 days after injection. Patient then started getting warmth at the site of the localized redness at site of injection starting on Tuesday 4/1/25, 5 days after injection. Patient did not take anything for self treatment. Patient reported to the pharmacy on Wednesday 4/2/25 and was counseled to apply cold compress, take an antihistamine, and anti-inflammatory over the counter and monitor for improvement. If symptoms getting worse and not better, patient was counseled to contact VAERS, the pharmacy, and/or seek urgent care treatment.

Current illness

unknown

Medical history

cardiac

Other medications

Atorvastatin, alendronate, omega-3-acid, amlodipine, metoprolol, synthroid

Allergies

Sulfa drugs

Lab data

none